PRECLINICAL ASSESSMENT OF IPH6501, A FIRST-IN-CLASS IL2V-ARMED TETRASPECIFIC NK CELL ENGAGER DIRECTED AGAINST CD20 FOR R/R B-NHL, IN COMPARISON WITH A CD20-TARGETING T CELL ENGAGER
EHA Library, Eric Vivier,
419338
EFFECTIVENESS OF ORAL RUXOLITINIB FOR ACUTE GVHD PROPHYLAXIS AFTER HAPLOIDENTICAL BONE MARROW TRANSPLANTATION IN PATIENTS WITH SEVERE APLASTIC ANEMIA: A PHASE Ⅱ,SINGLE-CENTER, SINGLE-COHORT, PROSPECTIVE CLINICAL TRIAL
EHA Library, Yang Yan,
419417